All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 2018-12-07? to Fri 2026-01-30 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+49.14%
2026-01-30 |
1.838 TRR
2026-01-30 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2026-01-30 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+83.78%
+8.89%/yr |
+2.27%/yr
(R2=0.003) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2026-01-30 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$18,377.81
2026-01-30 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2026 (YTD) | +49.14% |
| 2025 | −30.93% |
| 2024 | −59.36% |
| 2023 | −46.42% |
| 2022 | −33.57% |
| 2021 | +127.12% |
| 2020 | +426.86% |
| 2019 | +25.23% |
| 2018 | −17.68% |
| Fri 2018-12-07? to Fri 2026-01-30 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × | −92.35% |
−96.11%
2025-11-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||